hotspot -WSS

hotspot

author：leisure time 2025-10-02 22:28:15 - browse：918

Babies born by in vitro fertilization — when a woman’s egg is fertilized outside of her body and then implanted back into her uterus — skew more heavily male than babies conceived naturally. A study published Monday in the Proceedings of the National Academy of Sciences sheds light on why that happens.

You’ll want to know:

During normal development, female embryos usually shut down the activity of one of their two X chromosomes to keep gene expression levels the same as in male embryos. But researchers at the China Agricultural University saw that this process often went awry in mouse embryos created by IVF. Those female embryos were defective and didn’t develop properly. Researchers said it might be possible to fix the problem by adding a particular chemical (a derivative of vitamin A) to embryos in the lab dish before they’re implanted.

The background:

More than 5 million people have been born using IVF since it was pioneered in 1978. Skewed sex ratio has been debated for decades; one 2010 study found IVF produced as many as 128 boys born for every 100 girls.

Keep in mind:

The study was carried out on IVF embryos in mice, with naturally conceived mouse embryos as the control group. While mice are a commonly used research subject, findings in rodents don’t always translate directly to the biology of humans.

Also note that IVF births account for just 1 to 2 percent of total births in the United States, so having more males born via fertility treatments is unlikely to affect the gender ratio of babies nationwide. “I don’t think anyone should be worried even if there’s a slight increase in male births in patients undergoing fertility care,” said Dr. Mark Sauer, an obstetrician and gynecologist at Columbia University Medical Center, who was not involved in the study.

The bottom line:

Scientists might have figured out the cause for the skewed sex ratio that shows up in IVF births, but it’s not clear yet whether the strategies they propose to fix the issue will work in practice.

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： New weight loss drugs vying to be the next Wegovy or Mounjaro

entertainment

WSS

Long Covid needs a new name — and a new frame

A common UTI test for kids haunts adults as a traumatic 'nightmare'

At ASCO, AstraZeneca reports strong data for breast cancer drug

With trial win, GSK could get blood cancer drug back on market

ASCO: AstraZeneca's hat trick, and palliative care's spotlight

PEPFAR is under serious threat — and so is global health

entertainment

hotspot

You’ll want to know:

The background:

Keep in mind:

The bottom line:

hotspot

Trump demands the U.S. pay no more for drugs than other countries … again

Change Healthcare can notify patients about the breach, HHS says

23andMe had bad news about my health. I wish a person had delivered it

ASCO 2024: 'Reassuring' Corbus data on ADC bladder cancer drug

BioMarin wins approval for gene therapy to treat hemophilia A

IRA could hurt research into orphan drugs for rare diseases

Novavax promises a turnaround & Lilly roils the obesity market

The Pandemic Treaty must support building strong health systems

Medicare proposal to cover medical devices draws a mixed reaction

Will the IRA bring competition to the biologics market?

focus

Ultragenyx gene therapy for rare liver ailment succeeds in late

Popular nasal decongestant doesn't actually relieve congestion

Letters to First Opinion on caregivers, digital health, and more

See how much Covid

What to make of Biden’s latest efforts on cancer research

What to make of Biden’s latest efforts on cancer research

focus

hotspot

entertainment

knowledge